Back

Relation between terminal QRS axis and response to cardiac resynchronization therapy

18 June 2017 (15:30 - 16:30)
Organised by:
Congress Presentation Part of: Moderated Poster session 2 - CRT, indications and outcome Results (Resynchronization therapy) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Pieter Koopman

Heart Centre Hasselt, Hasselt (Belgium)

9 More presentations in this session

Presentation thumbnail
Left ventricular pacing polarity and survival following cardiac resynchronization therapy
Doctor S. Mittal (Ridgewood, US)
Abstract Slides
Presentation thumbnail
Comprehensive economic analysis of automatic optimization algorithms in cardiac resynchronization defibrillators (CRT-Ds): Markov modelling under the Italian, Spanish and UK healthcare settings
Doctor A. Maan (Cranston, US)
Abstract Slides
Presentation thumbnail
Relationship between indication for cardiac resynchronization therapy implantation and long-term survival
Doctor S. Mittal (Ridgewood, US)
Abstract Slides
Presentation thumbnail
Adherence to ESC guidelines class I was associated to better prognosis, clinical response and LV reverse remodeling in a large real-world CRT population.
Doctor A. Ferraro (Rivoli, IT)
Abstract
Presentation thumbnail
Effect of gender on patient selection for cardiac resynchronisation therapy
Professor A. Quesada Dorador (Valencia, ES)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster session 2 - CRT, indications and outcome

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response
1 September 2020
thumbnail
Congress Session
ESC/EHRA Consensus Paper on Conduction System Pacing
30 March 2025
thumbnail
Congress Presentation
Hemodynamic forces from 4D flow magnetic resonance imaging for optimised prediction of cardiac resynchronisation therapy outcome
27 August 2023
thumbnail
Congress Session
Personalised approaches to devices in heart failure
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources